| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.17 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |